Search Results
Baxter Named to Dow Jones Sustainability Indices for 23rd Consecutive Year
Baxter International Inc. (NYSE: BAX), a global medtech leader, today announced it was again named to the Dow Jones Sustainability Indices (DJSI), including both DJSI World and DJSI North America. Baxter has proudly been included in the DJSI World and DJSI North America each year since they launched, in 1999 and 2005, respectively.
Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announces the launch of the ExactaMix Pro Automated Compounder, which is expected to be available to customers in the United States in early 2023. ExactaMix Pro will be on display at Baxter’s booth #937 at the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting taking place Dec. 4 – Dec. 8, 2022, in Las Vegas.
Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through May 30, 2023. About Baxter
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 3, 2023, to shareholders of record as of December 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter
'It's About the Patient & Purpose'
For Darren Evans, work is not simply a job, it's a career with a larger purpose. As vice president, Global Technical Services at Baxter, Darren's teams ensure our customers have the equipment and technology they need to serve their patients. We spoke with Darren, who joined Baxter as part of the company's recent acquisition of Hillrom, to learn about how he and his team support patients and customers on a daily basis.
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida. Key data highlighted include:
Activating Our Passion to Increase Kidney Care Access
We spoke with Peter Rutherford, MB BS, PhD, FRCP, vice president of Worldwide Medical Affairs for our Renal Care business, about his experience as a practicing nephrologist and his quest to improve global access to kidney care and patient outcomes.
Baxter Reports Third-Quarter 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2022.
Carrying our Culture to New Heights
Our nine Business Resource Groups (BRGs) are an important component in growing our diverse, equitable and inclusive culture and advancing our priorities as a company. These voluntary, employee-run affinity groups share identities and experiences that help drive better outcomes on behalf of our workforce, marketplace and communities.
The Baxter International Foundation Announces $3 Million In New Grants To Organizations Working To Advance Racial Justice
The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), announced today it will provide a combined $3 million in new racial justice grants in 2022 to multiple organizations working in the United States.